Development of O/W nanoemulsions for ophthalmic administration of timolol.

[1]  Jia-bi Zhu,et al.  [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate]. , 2011, Yao xue xue bao = Acta pharmaceutica Sinica.

[2]  S. Vyas,et al.  Carbopol/Chitosan Based pH Triggered In Situ Gelling System for Ocular Delivery of Timolol Maleate , 2010, Scientia pharmaceutica.

[3]  L. Gan,et al.  Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability , 2010, Acta Pharmacologica Sinica.

[4]  S. Vyas,et al.  Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation , 2010, Journal of drug targeting.

[5]  Maria Jose Alonso,et al.  Chitosan-based nanostructures: a delivery platform for ocular therapeutics. , 2010, Advanced drug delivery reviews.

[6]  S. Harding,et al.  Polysaccharide drug delivery systems based on pectin and chitosan , 2010, Biotechnology & genetic engineering reviews.

[7]  A. Mahmoud,et al.  Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride , 2009, AAPS PharmSciTech.

[8]  D. K. Majumdar,et al.  Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[9]  Tiffany Jm.  Surface tension in tears. , 2006 .

[10]  J. Tiffany.  Surface tension in tears. , 2006, Archivos de la Sociedad Espanola de Oftalmologia.

[11]  A. Ludwig,et al.  The use of mucoadhesive polymers in ocular drug delivery. , 2005, Advanced drug delivery reviews.

[12]  D. Aggarwal,et al.  Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. , 2005, International journal of pharmaceutics.

[13]  J. Ditlev,et al.  Corneal permeability in a redesigned corneal holder for the bovine cornea opacity and permeability assay. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  S. Fialho,et al.  New vehicle based on a microemulsion for topical ocular administration of dexamethasone , 2004, Clinical & experimental ophthalmology.

[15]  Simon Benita,et al.  The potential of lipid emulsion for ocular delivery of lipophilic drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Akira Ohtori,et al.  Improvement of the ocular bioavailability of timolol by sorbic acid. , 2004, International journal of pharmaceutics.

[17]  M. Groves,et al.  The Influence of Free Fatty Acid Formation on the pH of Phospholipid-Stabilized Triglyceride Emulsions , 1993, Pharmaceutical Research.

[18]  D. Mcclements,et al.  Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes. , 2003, Journal of agricultural and food chemistry.

[19]  R. Gurny,et al.  Ocular tolerance of preservatives and alternatives. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  T. Vandamme.  Microemulsions as ocular drug delivery systems: recent developments and future challenges , 2002, Progress in Retinal and Eye Research.

[21]  Indu Pal Kaur,et al.  Ocular Preparations: The Formulation Approach , 2002, Drug development and industrial pharmacy.

[22]  Y. Y. Wang,et al.  Effect of liposomes and niosomes on skin permeation of enoxacin. , 2001, International journal of pharmaceutics.

[23]  K R Wilhelmus,et al.  The Draize eye test. , 2001, Survey of ophthalmology.

[24]  Robert Gurny,et al.  Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. , 1999, International journal of pharmaceutics.

[25]  A. Haβe,et al.  Development and characterization of microemulsions for ocular application , 1997 .

[26]  A. Kabalnov,et al.  Phospholipids as Emulsion Stabilizers: 2. Phase Behavior versus Emulsion Stability , 1996 .

[27]  Y. Tsai,et al.  The Preparation of Norfloxacin‐loaded Liposomes and their In‐vitro Evaluation in Pig's Eye , 1996, The Journal of pharmacy and pharmacology.

[28]  H. Jun,et al.  Effectiveness and Mode of Action of Isopropyl Myristate as a Permeation Enhancer for Naproxen through Shed Snake Skin , 1996, The Journal of pharmacy and pharmacology.

[29]  P. Casterton,et al.  A Novel Approach to Assessing Eye Irritation Potential Using the Bovine Corneal Opacity and Permeability Assay , 1996 .

[30]  L. Salminen,et al.  Ocular inserts for topical delivery , 1995 .

[31]  V. H. Lee.  Precorneal, corneal, and postcorneal factors , 1993 .

[32]  J. Sina,et al.  Bovine corneal opacity and permeability test : an in vitro assay of ocular irritancy , 1992 .

[33]  A. Rozier,et al.  Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol , 1992 .

[34]  J. Sina,et al.  Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[35]  M. Gallarate,et al.  Influence of octanoic acid on membrane permeability of timolol from solutions and from microemulsions , 1988 .

[36]  O. Camber.  An in vitro model for determination of drug permeability through the cornea. , 1985, Acta pharmaceutica Suecica.